What is nuclear scintigraphy?
Nuclear scintigraphy, using both planar and SPECT imaging, is a non-invasive, commonly available diagnostic tool with high sensitivity and specificity for ATTR-CM when combined with testing to rule out AL amyloidosis.1-3
To facilitate early diagnosis of ATTR-CM, nuclear scintigraphy should be more broadly considered in patients with the following characteristics3:
If myocardial tracer uptake is visually present on the SPECT image, then proceed to step 2; Semiquantitative visual grading.
Radiograph showing 99mTc-PYP/99mTc-DPD/99mTc-HMDP* uptake.
Adapted from Dorbala et al. J Nucl Cardiol. 2019.
If no myocardial tracer uptake is present on SPECT, then visual grade is 0
Radiograph showing 99mTc-PYP/99mTc-DPD/99mTc-HMDP* uptake.
Adapted from Dorbala et al. J Nucl Cardiol. 2019.
Radiograph showing 99mTc-PYP/99mTc-DPD/99mTc-HMDP* uptake.
Adapted from Dorbala et al. J Nucl Cardiol. 2019.
Interpretation of the visual scoring method in relation to the bone (rib) uptake at 3 hours3 is as follows:
When cardiac amyloidosis is suspected, Grade 2 or 3 myocardial uptake with concurrent testing to rule out AL is diagnostic of ATTR-CM.3,‡,§
Quantification of cardiac 99mTc-PYP* uptake using the H/CL ratio4
Radiograph showing quantification of cardiac 99mTc-PYP* uptake using H/CL ratio.
EMB — an invasive approach to diagnose ATTR-CM
If the clinical suspicion for cardiac amyloidosis remains high despite a negative or inconclusive scintigraphy scan, then consider EMB.1
EMB requires histology for diagnosis; positive Congo red staining with apple-green birefringence under polarised light is indicative of ATTR-CM.1,5
Congo red staining of myocardial tissue in light microscopy and apple-green birefringence in polarised light microscopy1
Genetic testing — in the ATTR-CM diagnostic process
An approach for patients with suspected cardiac amyloidosis; this approach includes testing for monoclonal protein followed by scintigraphy and/or biopsy.7
Meet Dr. Detective, a cardiologist who is specialised in diagnosing tough cases. Watch as he detects ATTR-CM in his patients.
Encountering ATTR-CM
Raising suspicion of ATTR-CM
Detecting ATTR-CM
Gain a deeper understanding of echo and CMR.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.
Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.
Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.